BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 419741)

  • 1. [Age distribution of the incidence and immune structure of the pediatric population in epidemic parotitis].
    Lazikova GF; Vardanian NV; Nikolaevskiĭ GP
    Vopr Virusol; 1979; (1):64-6. PubMed ID: 419741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The incidence of epidemic mumps and the rate of antibody detection in different age groups of Moscow population].
    Andreeva AP; Pille ER; Babueva AD; Sarycheva OF
    Vopr Virusol; 1975; (4):463-6. PubMed ID: 1216840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occurrence of antibodies against epidemic parotitis virus among the population of Poland].
    Imbs D; Loza-Tulimowska M; Rudnicka H
    Przegl Epidemiol; 1984; 38(4):361-8. PubMed ID: 6533680
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of mumps].
    Kaptsova TI
    Feldsher Akush; 1983; 48(4):7-10. PubMed ID: 6552997
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laboratory diagnosis of parotitis in the post-vaccination era].
    de la Loma A; Villota J; Varela JM; Alonso M; de Ory F
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):119-20. PubMed ID: 12586040
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mumps vaccine virus transmission].
    Otrashevskaia EV; Kulak MV; Otrashevskaia AV; Karpov IA; Fisenko EG; Ignat'ev GM
    Vopr Virusol; 2013; 58(6):42-5. PubMed ID: 24772647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2001 serological survey in the Czech Republic--mumps.
    Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S50-3. PubMed ID: 15080260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.
    Avijgan M; Habibian R; Kheiri S
    East Mediterr Health J; 2009; 15(2):295-301. PubMed ID: 19554975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comment on: Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D: Studies of the mumps epidemic in vaccinated children in Western Switzerland].
    Gasser-Bachmann M
    Schweiz Med Wochenschr; 1997 Nov; 127(47):1970-1. PubMed ID: 9480538
    [No Abstract]   [Full Text] [Related]  

  • 12. Mumps control today.
    Quinlisk MP
    J Infect Dis; 2010 Sep; 202(5):655-6. PubMed ID: 20662719
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mumps in Poland in 2004].
    Stefanoff P
    Przegl Epidemiol; 2006; 60(3):389-92. PubMed ID: 17249158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of mumps in preschool institutions using a live mumps vaccine made from strain L-3].
    Garaseferian MG; Bolotovskiĭ VM; Shatrova LP; Titova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):39-42. PubMed ID: 2970740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G; Petersen I; Mordhorst CH
    Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay of mumps antibody for evaluation of immune status before and after vaccination.
    Kuno-Sakai H; Iwasaki H; Kimura M
    J Infect Dis; 1984 May; 149(5):813. PubMed ID: 6726005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The results of an immunoepidemiological examination of foci of epidemic parotitis].
    Bolotovskiĭ VM; Gelikman BG; Mikheeva IV; Shubin NS; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):42-6. PubMed ID: 2239003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemic parotitis: etiology, epidemiology and prevention].
    Crovari P
    G Mal Infett Parassit; 1969 Jun; 21(5):337-48. PubMed ID: 5364694
    [No Abstract]   [Full Text] [Related]  

  • 20. Serological survey of parainfluenza and parotitis in the population of Czechoslovakia.
    Pecenková I; Tůmová B; Fedová D; Pecenka J
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):173-83. PubMed ID: 170333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.